These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 37034479)

  • 61. The Advancing Roles of Exosomes in Breast Cancer.
    Wang X; Sun C; Huang X; Li J; Fu Z; Li W; Yin Y
    Front Cell Dev Biol; 2021; 9():731062. PubMed ID: 34790660
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions.
    Hazafa A; Mumtaz M; Farooq MF; Bilal S; Chaudhry SN; Firdous M; Naeem H; Ullah MO; Yameen M; Mukhtiar MS; Zafar F
    Life Sci; 2020 Dec; 263():118525. PubMed ID: 33031826
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy.
    Liang C; Xu L; Song G; Liu Z
    Chem Soc Rev; 2016 Nov; 45(22):6250-6269. PubMed ID: 27333329
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations.
    Fares J; Kanojia D; Rashidi A; Ahmed AU; Balyasnikova IV; Lesniak MS
    Clin Breast Cancer; 2019 Dec; 19(6):383-391. PubMed ID: 31262686
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer-Challenges and Opportunities.
    Li Y; Humphries B; Yang C; Wang Z
    Nanomaterials (Basel); 2018 May; 8(6):. PubMed ID: 29794968
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.
    Li YJ; Wu JY; Wang JM; Xiang DX
    J Control Release; 2020 Apr; 320():105-111. PubMed ID: 31978441
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Are capecitabine and the active metabolite 5-Fu CNS penetrable to treat breast cancer brain metastasis?
    Zhang J; Zhang L; Yan Y; Li S; Xie L; Zhong W; Lv J; Zhang X; Bai Y; Cheng Z
    Drug Metab Dispos; 2015 Mar; 43(3):411-7. PubMed ID: 25547867
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Improving orthotopic mouse models of patient-derived breast cancer brain metastases by a modified intracarotid injection method.
    Liu Z; Wang Y; Kabraji S; Xie S; Pan P; Liu Z; Ni J; Zhao JJ
    Sci Rep; 2019 Jan; 9(1):622. PubMed ID: 30679540
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New insights and emerging therapies for breast cancer brain metastases.
    Lim E; Lin NU
    Oncology (Williston Park); 2012 Jul; 26(7):652-9, 663. PubMed ID: 22888567
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Explorations of CRISPR/Cas9 for improving the long-term efficacy of universal CAR-T cells in tumor immunotherapy.
    Naeem M; Hazafa A; Bano N; Ali R; Farooq M; Razak SIA; Lee TY; Devaraj S
    Life Sci; 2023 Mar; 316():121409. PubMed ID: 36681183
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brain Metastases from Breast Cancer and Response to Treatment with Eribulin: A Case Series.
    Chang AY; Ying XX
    Breast Cancer (Auckl); 2015; 9():19-24. PubMed ID: 26052228
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular aspects of brain metastases in breast cancer.
    Tomasik B; Bieńkowski M; Górska Z; Gutowska K; Kumięga P; Jassem J; Duchnowska R
    Cancer Treat Rev; 2023 Mar; 114():102521. PubMed ID: 36736124
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeted Delivery of Secretory Promelittin via Novel Poly(lactone-
    Zhou Y; Zhang S; Chen Z; Bao Y; Chen AT; Sheu WC; Liu F; Jiang Z; Zhou J
    Adv Sci (Weinh); 2020 Mar; 7(5):1901866. PubMed ID: 32154067
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risk factors for breast cancer brain metastases: a systematic review.
    Koniali L; Hadjisavvas A; Constantinidou A; Christodoulou K; Christou Y; Demetriou C; Panayides AS; Pitris C; Pattichis CS; Zamba-Papanicolaou E; Kyriacou K
    Oncotarget; 2020 Feb; 11(6):650-669. PubMed ID: 32110283
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics.
    Bhat AA; Nisar S; Mukherjee S; Saha N; Yarravarapu N; Lone SN; Masoodi T; Chauhan R; Maacha S; Bagga P; Dhawan P; Akil AA; El-Rifai W; Uddin S; Reddy R; Singh M; Macha MA; Haris M
    J Transl Med; 2022 Nov; 20(1):534. PubMed ID: 36401282
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1.
    Doheny D; Manore S; Sirkisoon SR; Zhu D; Aguayo NR; Harrison A; Najjar M; Anguelov M; Cox AO; Furdui CM; Watabe K; Hollis T; Thomas A; Strowd R; Lo HW
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077791
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Sirkisoon SR; Carpenter RL; Rimkus T; Doheny D; Zhu D; Aguayo NR; Xing F; Chan M; Ruiz J; Metheny-Barlow LJ; Strowd R; Lin J; Regua AT; Arrigo A; Anguelov M; Pasche B; Debinski W; Watabe K; Lo HW
    Oncogene; 2020 Jan; 39(1):64-78. PubMed ID: 31462709
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Advances in the Molecular Landscape of Lung Cancer Brain Metastasis.
    Souza VGP; de Araújo RP; Santesso MR; Seneda AL; Minutentag IW; Felix TF; Hamamoto Filho PT; Pewarchuk ME; Brockley LJ; Marchi FA; Lam WL; Drigo SA; Reis PP
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.